首页|入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平与CHB肝纤维化严重程度的相关性及对疾病预后的预测价值

入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平与CHB肝纤维化严重程度的相关性及对疾病预后的预测价值

扫码查看
目的 探讨入院时血清转化生长因子-β1(TGF-β1)、Smad同源蛋白2(Smad2)、Smad同源蛋白3(Smad3)及透明质酸(HA)、Ⅲ型前胶原(PCⅢ)、层黏连蛋白(LN)、Ⅳ型胶原(CⅣ)水平与慢性乙型肝炎(CHB)肝纤维化严重程度的相关性及联合检测对疾病预后的预测价值.方法 选取河南省中医院2021年3月至2022年3月收治的78例CHB肝纤维化患者作为研究组,选择同期78名健康体检者作为对照组.比较研究组和对照组及不同肝纤维化分期、不同炎症活动分级CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平;分析入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平与肝纤维化分期、炎症活动分级的相关性.CHB肝纤维化患者治疗3个月后,根据患者预后分为预后良好和预后不良亚组,比较预后良好和预后不良患者入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平;分析入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平联合检测对CHB肝纤维化患者预后不良的预测价值.结果 研究组入院时血清TGF-β1、Smad2、Smad3、HA、LN、PC Ⅲ、CⅣ高于对照组(P<0.05);不同肝纤维化分期、炎症活动分级CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、LN、PC Ⅲ、CⅣ比较:S1<S2<S3<S4、G1<G2<G3<G4,差异有统计学意义(P<0.05);入院时血清 TGF-β1、Smad2、Smad3、HA、LN、PC Ⅲ、CⅣ水平与肝纤维化分期、炎症活动分级均呈正相关(P<0.05).预后良好患者入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平均低于预后不良患者(P<0.05);入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平联合预测肝纤维化患者预后不良的曲线下面积(AUC)优于各指标单一检测(P<0.05).结论 CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、PC Ⅲ、LN、CⅣ水平均呈现高表达,且与肝纤维化分期、炎症活动分级密切相关,其联合检测对CHB肝纤维化患者预后有较高的预测价值,可用于评估CHB肝纤维化患者病情严重程度和预后,为制定针对性治疗措施提供参考.
Correlation of Serum Levels of TGF-β1,Smad2,Smad3,HA,LN,PC Ⅲ,CⅣat Admission with the Severity of CHB Liver Fibrosis and the Predictive Value of Combined Detection for Disease Prognosis
Objective To investigate the correlation of serum levels of transforming growth factor-β1(TGF-β1),Smad homologous protein 2(Smad2),Smad homologous protein 3(Smad3),hyaluronic acid(HA),type Ⅲ procollagen(PC Ⅲ),laminin(LN)and type Ⅳ collagen(CⅣ)levels with the severity of chronic hepatitis B(CHB)liver fibrosis and the predictive value of combined detection for disease prognosis.Methods A total of 78 patients with CHB liver fibrosis admitted to Henan Hospital of Traditional Chinese Medicine from March 2021 to March 2022 were selected as the study group,and 78 healthy subjects in the same period were selected as the control group.The serum levels of TGF-β1,Smad2,Smad3,HA,PC Ⅲ,LN and CⅣ at admission were compared between the study group and the control group,and among different stages of liver fibrosis and different levels of inflammatory activity in CHB patients with liver fibrosis.The correlation of serum levels of TGF-β1,Smad2,Smad3,HA,PC Ⅲ,LN,CⅣ at admission with the stage of hepatic fibrosis and the grade of inflammatory activity was analyzed.After 3 months of treatment,according to the different prognosis,the CHB liver fibrosis patients were divided into good prognosis and poor prognosis subgroups.The serum levels of TGF-β1,Smad2,Smad3,HA,PC Ⅲ,LN and CⅣ at admission were compared between good prognosis and poor prognosis of CHB liver fibrosis patients.The predictive value of TGF-β1,Smad2,Smad3,HA,PC Ⅲ,LN and CⅣ levels at admission combined detection for the prognosis of CHB liver fibrosis patients was analyzed.Results The serumlevels of TGF-β1,Smad2,Smad3,HA,LN,PC Ⅲ and CⅣ at admission in the study group were higher than those in the control group(P<0.05).There were significant differences in serum levels of TGF-β1,Smad2,Smad3,HA,LN,PC Ⅲ and CⅣ at admission in different liver fibrosis stage and different inflammatory activity of patients with CHB liver fibrosis:Sl<S2<S3<S4,Gl<G2<G3<G4(P<0.05).Serum levels of TGF-β1,Smad2,Smad3,HA,LN,PC Ⅲ,C Ⅳ at admission were positively correlated with liver fibrosis stage and inflammatory activity grade(P<0.05).After treatment,the serum levels of TGF-β1,Smad2,Smad3,HA,LN,PC Ⅲ and CⅣ at admission in good prognosis of CHB liver fibrosis patients were lower than those in poor prognosis patients(P<0.05).The combination of TGF-β1/Smads signaling pathway indexes and liver fibrosis indexes predicted the poor prognosis of patients with AUC better than the single detection of each indicator.Conclusion The serum levels of TGF-β1,Smad2,Smad3,HA,PC Ⅲ,LN and CⅣ at admission are highly expressed in CHB liver fibrosi spatients,which are closely related to the stage of hepatic fibrosis and the grade of inflammatory activity.The above serum indicators combined detection has higher prognostic value for the prognosis of CHB liver fibrosis patients,which can be used to evaluate the severity and prognosis of CHB hepatic fibrosis patients,and provide reference for formulating targeted treatment measures.

chronic hepatitis Bliver fibrosistransforming growth factor-β1Smad homologous protein 2Smad homologous protein 3hyaluronic acidtype Ⅰ Ⅱ procollagenlaminintype Ⅳ collagenseverityprognosis

张艳敏、李登州、陈秋芳、王海颖

展开 >

河南省中医院检验科,河南郑州 450000

慢性乙型肝炎 肝纤维化 转化生长因子-β1 Smad同源蛋白2 Smad同源蛋白3 透明质酸 Ⅲ型前胶原 层黏连蛋白 Ⅳ型胶原 严重程度 预后

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(6)
  • 22